These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38931409)

  • 41. Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    Etekochay MO; Amaravadhi AR; González GV; Atanasov AG; Matin M; Mofatteh M; Steinbusch HW; Tesfaye T; Praticò D
    J Alzheimers Dis; 2024; 99(1):1-20. PubMed ID: 38640152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach.
    Proctor CJ; Pienaar IS; Elson JL; Kirkwood TB
    Mol Neurodegener; 2012 Jul; 7():32. PubMed ID: 22748062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease.
    Schaduangrat N; Prachayasittikul V; Choomwattana S; Wongchitrat P; Phopin K; Suwanjang W; Malik AA; Vincent B; Nantasenamat C
    Med Res Rev; 2019 Sep; 39(5):1730-1778. PubMed ID: 30628099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of antibody-based therapies to treat Alzheimer's disease: just a matter of timing?
    Cedernaes J; Schiöth HB; Benedict C
    Exp Gerontol; 2014 Sep; 57():104-6. PubMed ID: 24835192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of the advances, insights, and prospects of gene therapy for Alzheimer's disease: A novel target for therapeutic medicine.
    Ataei B; Hokmabadi M; Asadi S; Asadifard E; Aghaei Zarch SM; Najafi S; Bagheri-Mohammadi S
    Gene; 2024 Jun; 912():148368. PubMed ID: 38485038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addressing Alzheimer's Disease (AD) Neuropathology Using Anti-microRNA (AM) Strategies.
    Jaber VR; Zhao Y; Sharfman NM; Li W; Lukiw WJ
    Mol Neurobiol; 2019 Dec; 56(12):8101-8108. PubMed ID: 31183807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
    Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Raturi A; Yadav V; Hoda N; Subbarao N; Chaudhry SA
    J Biomol Struct Dyn; 2024; 42(21):11555-11573. PubMed ID: 37822182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration.
    Sen D; Rathee S; Pandey V; Jain SK; Patil UK
    Curr Alzheimer Res; 2024 Apr; ():. PubMed ID: 38623983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advancements toward therapeutic vaccines against Alzheimer's disease.
    Herline K; Drummond E; Wisniewski T
    Expert Rev Vaccines; 2018 Aug; 17(8):707-721. PubMed ID: 30005578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial intelligence for drug discovery and development in Alzheimer's disease.
    Qiu Y; Cheng F
    Curr Opin Struct Biol; 2024 Apr; 85():102776. PubMed ID: 38335558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer's Disease.
    Mishra S; Stany B; Das A; Kanagavel D; Vijayan M
    Mol Neurobiol; 2024 Nov; 61(11):8739-8758. PubMed ID: 38558361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's Disease: Treatment Strategies and Their Limitations.
    Passeri E; Elkhoury K; Morsink M; Broersen K; Linder M; Tamayol A; Malaplate C; Yen FT; Arab-Tehrany E
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of engineered antibodies (scFvs and nanobodies) targeting pathological protein aggregates in Alzheimer's disease.
    Zhang Y; Yu W; Zhang L; Li P
    Expert Opin Investig Drugs; 2024 Oct; 33(10):1047-1062. PubMed ID: 39177331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules.
    Umar T; Hoda N
    Curr Top Med Chem; 2017; 17(31):3370-3389. PubMed ID: 29332579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.